The platform
TARA Skein represents a pioneering, centralised platform designed to enhance decision-making and patient care. This platform systematically gathers, evaluates, and interprets extensive health data specific to individuals suffering from migraines. It integrates a multifaceted array of data sources, thereby enriching the insights garnered. These sources include detailed patient diaries, which chronicle triggers, attack patterns, and medication usage; patient-reported outcomes submitted via a specialised application; and quantitative data derived from wearable technology.
Furthermore, TARA Skein functions as a comprehensive health data repository, accessible to researchers. This access facilitates the discovery of nuanced patterns and insights into the intricate nature of migraine conditions. The ultimate objective is to refine and tailor treatment approaches, thereby augmenting the effectiveness of decision support systems in patient care. This innovative approach exemplifies the commitment to advancing healthcare through data-driven strategies, ensuring more personalised and effective treatment modalities for migraine sufferers.
Skein works together with patients and carers, as well as other healthcare professionals, to develop tools for delivering personalised treatments based on patient data collected via smartphone apps. This could help improve compliance with treatment plans by tailoring them according to each individual’s needs and circumstances.
Personalised medicine for migraine is based on the identification of early markers that indicate who, when and how will be affected by migraine. The researchers want to use biomarkers to identify a single or combination of factors that are suitable for early diagnosis, but also for the determination of the patient’s disease stage and progression.